ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0153

Frequencies and Rates of All-Cause Emergency Visits and Hospitalizations in Persons with Inflammatory Arthritis Conditions and Gout: A Systematic Review

Kara Irwin, Ran Huo, Claire Barber and Cheryl Barnabe, University of Calgary, Calgary, AB, Canada

Meeting: ACR Convergence 2024

Keywords: Access to care, Epidemiology, Health Care, Health Services Research

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 16, 2024

Title: Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Despite advances in the management of inflammatory arthritis (IA) and gout, many patients still access acute care services. This may be related to their arthritis conditions, associated comorbidities, or other factors. The magnitude of this use, and the variations related to contextual factors such as health system or personal characteristics is unknown. This review sought to estimate the proportion (%) and/or rate (events per 100 person years) of all-cause emergency department (ED) visits or hospitalizations in IA or gout cohorts.

Methods: A systematic review was conducted in EMBASE and MedLine online databases for January 2000 to January 2024. Keywords for the search strategy were based on the types of arthritis conditions of interest (including RA, PsA, AS, JIA, and gout), as well as the type of acute care services of interest (ED visits and hospitalizations). Title and abstract screening, full-text review, and data extraction were completed independently by two researchers. Studies reporting either the proportion and/or rate of acute care use were included, with meta-analysis of the two outcomes conducted for each IA condition separately, and by available population membership strata were possible.

Results: From 8038 candidate studies, 1061 were selected for full-text review; 89 met inclusion criteria with data from 126 cohorts available. Studies focused largely on patients with RA (67% and 68% of studies reporting the proportion of ED visits or hospitalizations per year respectively, and 100% and 73% of studies reporting rate of ED visits or hospitalizations respectively) and no studies provided estimates for those with JIA. Over half (51%) of the cohorts reported estimates from American administrative datasets.

EDs were accessed by 20.4%, 24.4%, 25.4%, and 27.8% of individuals annually in PsA, AS, RA, and gout cohorts respectively. The proportion of cohort members requiring hospital admissions per year was similar in AS and RA at 15.2% and 15.7%, and in gout and PsA at 22.3% and 22.8% respectively. Hospitalization rates were similar across cohorts at 27.3 in PsA, 29.0 in Gout, 30.4 in RA, and 33.1 in AS cohorts per 100 person years.

Stratification of acute care use by PROGRESS+ characteristics was lacking. Out of 89 studies, 3 studies stratified by sex/gender, 2 by age, and 2 by First Nations status as well as rural/urban. Acknowledging the limited data, acute care use was higher for equity seeking groups in all available studies.

Conclusion: The proportions and rates of persons with IA conditions requiring acute care services were generally consistent across IA types, though the ranges seen within each IA type were large. Studies identified in this review reflected predominantly western health system structures. There is a paucity of data available for JIA, and for equity deserving group members in all IA conditions. Studies to understand the reasons for acute care use and possible interventions to reduce avoidable use is needed, as is further understanding of temporal trends in acute care use and needs to improve care models in equity-deserving groups.


Disclosures: K. Irwin: None; R. Huo: None; C. Barber: None; C. Barnabe: Amgen, 6, Janssen, 6.

To cite this abstract in AMA style:

Irwin K, Huo R, Barber C, Barnabe C. Frequencies and Rates of All-Cause Emergency Visits and Hospitalizations in Persons with Inflammatory Arthritis Conditions and Gout: A Systematic Review [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/frequencies-and-rates-of-all-cause-emergency-visits-and-hospitalizations-in-persons-with-inflammatory-arthritis-conditions-and-gout-a-systematic-review/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/frequencies-and-rates-of-all-cause-emergency-visits-and-hospitalizations-in-persons-with-inflammatory-arthritis-conditions-and-gout-a-systematic-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology